MLAB — Mesa Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00IndustrialsBalancedMid CapHigh Flyer
- $913.45m
- $1.08bn
- $184.34m
- 95
- 20
- 79
- 72
Annual cashflow statement for Mesa Laboratories, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
C2018 March 31st | 2019 March 31st | C2020 March 31st | 2021 March 31st | 2022 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.96 | 7.48 | 1.78 | 3.27 | 1.87 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 17.8 | 8.22 | 17.6 | 14.2 | 19.3 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 4.14 | 7.89 | -3.14 | 5.25 | -7.19 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 25.7 | 30.6 | 27 | 37.1 | 39.2 |
| Capital Expenditures | -2.8 | -1.26 | -1.5 | -1.99 | -4.43 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -14.4 | -2.62 | -184 | 0 | -301 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -17.2 | -3.88 | -186 | -1.99 | -305 |
| Financing Cash Flow Items | -0.905 | -0.68 | -5.44 | -0.968 | -0.237 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -9.02 | -21.7 | 231 | 146 | 52.6 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.351 | 4.72 | 71.2 | 182 | -215 |